Editorial: CCR5: A receptor at the center stage in infection

dc.contributor.authorEllwanger Joel Henrique
dc.contributor.authorSecchi Massimiliano
dc.contributor.authorAliberti Julio
dc.contributor.authorVangelista Luca
dc.date.accessioned2025-08-27T04:57:27Z
dc.date.available2025-08-27T04:57:27Z
dc.date.issued2022-10-18
dc.description.abstractThis editorial highlights the pivotal role of the chemokine receptor CCR5 in the context of infectious diseases. CCR5 has long been studied for its involvement in HIV pathogenesis, but emerging research demonstrates its broader significance in viral, bacterial, and inflammatory responses. The editorial introduces contributions that examine CCR5’s regulatory functions in immune cell trafficking, tissue inflammation, and therapeutic targeting. These studies provide new insights into the receptor’s dual role as a pathogen entry point and an immune modulator, suggesting novel avenues for vaccine and drug development.en
dc.identifier.citationEllwanger Joel Henrique; Secchi Massimiliano; Aliberti Julio; Vangelista Luca. (2022). Editorial: CCR5: A receptor at the center stage in infection. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2022.1054430en
dc.identifier.doi10.3389/fimmu.2022.1054430
dc.identifier.urihttps://doi.org/10.3389/fimmu.2022.1054430
dc.identifier.urihttps://nur.nu.edu.kz/handle/123456789/10473
dc.language.isoen
dc.publisherFrontiers Media SA
dc.rightsOpen accessen
dc.source(2022)en
dc.subjectCCR5, CCR5D32, gene-editing, COVID-19, HIV therapy, infection, maraviroc, leronlimab, type of access: open accessen
dc.titleEditorial: CCR5: A receptor at the center stage in infectionen
dc.typearticleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
10.3389_fimmu.2022.1054430.pdf
Size:
1.05 MB
Format:
Adobe Portable Document Format

Collections